Vyera Pharmaceuticals, which previously settled price-fixing charges that resulted in founder Martin Shkreli being banned from the pharmaceutical industry, filed for bankruptcy late Tuesday to sell its assets.
https://www.pharmalive.com/wp-content/uploads/2023/02/ReutersMartinShkreli2-10-2023.jpg8181200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-05-10 17:02:192023-05-11 09:20:39Martin Shkreli-founded drug company files for bankruptcy